CHICAGO and ITASCA, Ill. – Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture innovation and part of Ajinomoto Group, today announced a collaboration to evaluate Ajinomoto Group’s StemFit™ stem cell culture products using […]
New funding will power foundational primary cell data generation to advance AI-driven discovery through the company’s full product launch. MONTREAL and BOSTON — DropGenie, a biotechnology company advancing next-generation gene editing workflows, today announced the closing of its Seed+ financing to support the launch of its first product. The round was led by Skeleton Key, […]
The total funding comprises US$1 million in angel investment and a US$4 million seed round. The seed financing round was led by Wavemaker Ventures, with participation by SEEDS, further supported by notable investors across the United States and Asia. The financing will support the continued expansion of ChemT’s AI and experimental infrastructure, which aims to […]
The collaboration will evaluate Ajinomoto Group’s stem cell culture products using Syntax Bio’s programmable stem cell differentiation platform to support improved regenerative medicine discovery, development, and manufacturing. CHICAGO & ITASCA, Ill. — Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a […]
Boster Biological Technology, a life science reagent manufacturer based in Pleasanton, California, has broadened availability of its validated CD68 antibody marker, a rabbit monoclonal optimized for IHC performance in human FFPE specimens. Pleasanton, California, United States — Getting macrophage staining right in FFPE tissue has been a pain point for immunohistochemistry labs for years. Antigen […]
Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x’s single cell and spatial platforms PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced a research collaboration with Cleveland Clinic, a nonprofit multispecialty academic medical center that integrates clinical care […]
DURHAM, NC, USA and Cambridge, UK – Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, and EpiCypher®, the leading provider of ChIC/CUT&RUN technology, today announced a partnership to help researchers generate high-confidence epigenomic insights faster. By combining EpiCypher’s CUTANA™ ChIC/CUT&RUN platform with Abcam’s expertise in antibody development and characterization, the collaboration […]
New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines. JUPITER, Fla. — TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing […]
Amsbio has expanded its diverse range of recombinant and monoclonal antibodies to include over 10,000 new validated monospecific products in 15,000 formulations to support research in cancer, immunology, neuroscience, and signal transduction. Every antibody in the new catalogue has been subject to rigorous validation technologies to confirm that they selectively recognize their intended targets across applications such as immunohistochemistry, western […]
Strengthens Board with experienced industry executive, specializing in strategic planning, organizational leadership and commercial execution Cambridge, UK – Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today announced the appointment of Bruce Eaton, PhD as Chairman of the Board, with immediate effect. The appointment aligns with the […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
